ENTITY
SanBio Co Ltd

SanBio Co Ltd (4592 JP)

25
Analysis
Health CareJapan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
Refresh
11 Nov 2018 18:54

Japan: Moving Average Outliers - Results Driven

MOVING AVERAGE OUTLIERS - Our moving average outlier indicator uses a weighted sum of the share price relative to the 5-day, 20-day, 60-day, 120...

Logo
361 Views
Share
bullishSanBio Co Ltd
25 Oct 2018 17:03

Investment Thesis and Valuation

Key drivers / Concerns SanBio is a one drug company Key pipeline candidate, SB623 (allogeneic regenerative cell medicine for chronic motor deficit...

24 Sep 2018 17:36

Japan Fortnightly Update: Celebration

APATHY STRIKES AGAINTHE APATHY INDICATOR - Our Fortnightly Update for 26th August highlighted the lack of market activity after the end of the...

Logo
271 Views
Share
26 Aug 2018 16:31

Japan Fortnightly Update: Turning Point

TURNING POINT - Despite the last four trading days being 'up', the Japanese equity market composite fell by 0.6% over the last two weeks. New...

Logo
420 Views
Share
28 May 2018 18:08

Japan: Scoring Results & Forecasts - Part 3 - Company Winners & Losers

INTRODUCTION - The final part of our Results and Forecast/Revision Scores review will look at the leading and lagging performers and forecasters...

Logo
250 Views
Share
x